Proteostasis in neurodegenerative diseases
Advances in Clinical Chemistry · 2024
DOI: 10.1016/bs.acc.2024.04.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Clinical Chemistry, 2024. Verfasst von Sumit Kinger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Rajasthan, India. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Proteostasis, Proteasome Endopeptidase Complex, Autophagy. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 432 Literaturangaben. Gefördert von: Board of Research in Nuclear Sciences, Science and Engineering Research Board, Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Proteostasis is essential for normal function of proteins and vital for cellular health and survival. Proteostasis encompasses all stages in the "life" of a protein, that is, from translation to functional performance and, ultimately, to degradation. Proteins need native conformations for function and in the presence of multiple types of stress, their misfolding and aggregation can occur. A coordinated network of proteins is at the core of proteostasis in cells. Among these, chaperones are required for maintaining the integrity of protein conformations by preventing misfolding and aggregation and guide those with abnormal conformation to degradation. The ubiquitin-proteasome system (UPS) and autophagy are major cellular pathways for degrading proteins. Although failure or decreased functioning of components of this network can lead to proteotoxicity and disease, like neuron degenerative diseases, underlying factors are not completely understood. Accumulating misfolded and aggregated proteins are considered major pathomechanisms of neurodegeneration. In this chapter, we have described the components of three major branches required for proteostasis-chaperones, UPS and autophagy, the mechanistic basis of their function, and their potential for protection against various neurodegenerative conditions, like Alzheimer's, Parkinson's, and Huntington's disease. The modulation of various proteostasis network proteins, like chaperones, E3 ubiquitin ligases, proteasome, and autophagy-associated proteins as therapeutic targets by small molecules as well as new and unconventional approaches, shows promise.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Rajasthan, India.
- School of Biosciences and Bioengineering, Indian Institute of Technology Mandi, Mandi, Himachal Pradesh, India.
- Department of Biochemistry, University of Delhi South Campus, Dhaula Kuan, New Delhi, India.
- Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, Madhya Pradesh, India.
- Department of Biotechnology, Indian Institute of Technology Hyderabad, Telangana, India.
- Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Rajasthan, India. Electronic address: amit@iitj.ac.in.
Förderung
- Board of Research in Nuclear Sciences
- Science and Engineering Research Board
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Kinger, S., Jagtap, Y. A., Kumar, P., Choudhary, A., Prasad, A., Prajapati, V. K., Kumar, A., Mehta, G., & Mishra, A. (2024). Proteostasis in neurodegenerative diseases. Advances in Clinical Chemistry. https://doi.org/10.1016/bs.acc.2024.04.002
Vancouver
Kinger S, Jagtap YA, Kumar P, Choudhary A, Prasad A, Prajapati VK, et al. Proteostasis in neurodegenerative diseases. Advances in Clinical Chemistry. 2024. doi:10.1016/bs.acc.2024.04.002
BibTeX
@article{Kinger2024,
author = {Kinger, Sumit and Jagtap, Yuvraj Anandrao and Kumar, Prashant and Choudhary, Akash and Prasad, Amit and Prajapati, Vijay Kumar and Kumar, Amit and Mehta, Gunjan and Mishra, Amit},
title = {Proteostasis in neurodegenerative diseases},
journal = {Advances in Clinical Chemistry},
year = {2024},
doi = {10.1016/bs.acc.2024.04.002}
}
EUVIMED